Glyburide

CAS 10238-21-8 17 FDA-DMF suppliersSmall Molecule

Overview

Glyburide is an oral diabetes medication that helps control blood sugar levels by stimulating the release of the body's natural insulin. It is used to treat type 2 diabetes and is often prescribed in conjunction with diet and exercise.

API suppliers (19)

Suppliers of Glyburide backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.

  • USV PRIVATE LTD1 active DMF
  • Cadila Pharmaceuticals LimitedIndia1 active DMF
  • USV PRIVATE LTD1 active DMF
  • APITORIA PHARMA PRIVATE LTDIndia1 active DMF
  • USV PRIVATE LTD1 active DMF
  • CAMBREX PROFARMACO MILANO SRLItaly1 active DMF
  • Cadila Pharmaceuticals LimitedIndia1 active DMF
  • APITORIA PHARMA PRIVATE LTDIndia1 active DMF
  • ZENTIVA KS1 active DMF
  • Cadila Pharmaceuticals LimitedIndia1 active DMF
  • APITORIA PHARMA PRIVATE LTDIndia1 active DMF
  • ZENTIVA KS1 active DMF
  • FARMOS GROUP LTD MEDIPOLAR
  • CADILA LABORATORIES PVT LTD
  • SELOC FRANCE
  • HOECHST CELANESE CORP
  • USV LTD
  • CHUNGHWA CHEMICAL SYNTHESIS AND BIOTECH CO LTD
  • Cadila Healthcare LimitedIndia

Therapeutic areas

EndocrinologyDiabetes Management

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.